Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Dawid Zyla to Antibodies, Viral

This is a "connection" page, showing publications Dawid Zyla has written about Antibodies, Viral.

 
Connection Strength
 
 
 
1.705
 
  1. Zyla DS, Della Marca R, Lacarbonara D, Niemeyer G, Zipursky G, Di Clemente L, Verbruggen MHL, van Dijk LLA, Ceh OM, Jonathan-Trakht G, Kalantarov G, Acciani M, Laterza G, Vyshenska D, Leedale C, Pawlack E, Hastie KM, Horvat B, de Swart RL, de Vries RD, Greninger AL, Niewiesk S, Ollmann Saphire E, Porotto M. Structural and mechanistic basis for antibody neutralization of the measles fusion protein. Nat Commun. 2026 Apr 06; 17(1).
    View in: PubMed
    Score: 0.702
  2. Zyla DS, Della Marca R, Niemeyer G, Zipursky G, Stearns K, Leedale C, Sobolik EB, Callaway HM, Hariharan C, Peng W, Parekh D, Marcink TC, Diaz Avalos R, Horvat B, Mathieu C, Snijder J, Greninger AL, Hastie KM, Niewiesk S, Moscona A, Porotto M, Saphire EO. A neutralizing antibody prevents postfusion transition of measles virus fusion protein. Science. 2024 06 28; 384(6703):eadm8693.
    View in: PubMed
    Score: 0.621
  3. Acciani M, Zyla D, Niemeyer G, Harkins S, Parekh D, Pawlack E, Lacarbonara D, Kansara D, Ackerman ME, Niewiesk S, Porotto M, Hastie KM, Saphire EO. Human neutralizing antibodies targeting the measles virus hemagglutinin and fusion surface proteins. Cell Host Microbe. 2026 Jun 10; 34(6):1067-1081.e12.
    View in: PubMed
    Score: 0.177
  4. Hastie KM, Li H, Bedinger D, Schendel SL, Dennison SM, Li K, Rayaprolu V, Yu X, Mann C, Zandonatti M, Diaz Avalos R, Zyla D, Buck T, Hui S, Shaffer K, Hariharan C, Yin J, Olmedillas E, Enriquez A, Parekh D, Abraha M, Feeney E, Horn GQ, Aldon Y, Ali H, Aracic S, Cobb RR, Federman RS, Fernandez JM, Glanville J, Green R, Grigoryan G, Lujan Hernandez AG, Ho DD, Huang KA, Ingraham J, Jiang W, Kellam P, Kim C, Kim M, Kim HM, Kong C, Krebs SJ, Lan F, Lang G, Lee S, Leung CL, Liu J, Lu Y, MacCamy A, McGuire AT, Palser AL, Rabbitts TH, Rikhtegaran Tehrani Z, Sajadi MM, Sanders RW, Sato AK, Schweizer L, Seo J, Shen B, Snitselaar JL, Stamatatos L, Tan Y, Tomic MT, van Gils MJ, Youssef S, Yu J, Yuan TZ, Zhang Q, Peters B, Tomaras GD, Germann T, Saphire EO. Defining variant-resistant epitopes targeted by SARS-CoV-2 antibodies: A global consortium study. Science. 2021 Oct 22; 374(6566):472-478.
    View in: PubMed
    Score: 0.128
  5. Olmedillas E, Rajamanickam RR, Avalos RD, Ana-Sosa-Batiz F, Zyla D, Zandonatti MA, Harkins SS, Shresta S, Hastie KM, Saphire EO. Structure of a SARS-CoV-2 spike S2 subunit in a pre-fusion, open conformation. Cell Rep. 2025 Aug 26; 44(8):116052.
    View in: PubMed
    Score: 0.042
  6. Hastie KM, Yu X, Ana-Sosa-Batiz F, Zyla DS, Harkins SS, Hariharan C, Wasserman H, Zandonatti MA, Miller R, Maule E, Kim K, Valentine KM, Shresta S, Saphire EO. Potent Omicron-neutralizing antibodies isolated from a patient vaccinated 6 months before Omicron emergence. Cell Rep. 2023 05 30; 42(5):112421.
    View in: PubMed
    Score: 0.036
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)